Shamrock Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Shamrock Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3,749	Closed	-$412K	–	260
2018 Q2	$412K	Sell	3,749 -293	-7%	-$31.3K	0.25%	80
2018 Q1	$431K	Sell	4,042 -8,965	-69%	-$994K	0.26%	81
2017 Q4	$1.39M	Buy	13,007 +9,044	+228%	+$967K	0.82%	27
2017 Q3	$441K	Sell	3,963 -63	-2%	-$6.73K	0.28%	64
2017 Q2	$416K	Sell	4,026 -375	-9%	-$36.9K	0.26%	68
2017 Q1	$430K	Buy	+4,401	New	+$421K	0.27%	67
2016 Q1	–	Sell	-4,665	Closed	-$526K	–	266
2015 Q4	$526K	Sell	4,665 -390	-8%	-$42.3K	0.3%	70
2015 Q3	$511K	Buy	5,055 +4,908	+3,339%	+$589K	0.27%	65
2015 Q2	$18K	Sell	147 -15,522	-99%	-$1.86M	0.01%	192
2015 Q1	$1.79M	Sell	15,669 -8,847	-36%	-$976K	0.71%	24
2014 Q4	$2.48M	Buy	24,516 +984	+4%	+$95.6K	0.99%	21
2014 Q3	$2.15M	Sell	23,532 -1,428	-6%	-$125K	0.8%	32
2014 Q2	$2.14M	Sell	24,960 -2,028	-8%	-$160K	0.66%	40
2014 Q1	$2.13M	Sell	26,988 -3,024	-10%	-$252K	0.7%	33
2013 Q4	$2.27M	Sell	30,012 -2,805	-9%	-$199K	0.78%	36
2013 Q3	$2.29M	Buy	32,817 +13,008	+66%	+$852K	0.93%	27
2013 Q2	$1.18M	Buy	+19,809	New	+$1.15M	0.49%	50

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Shamrock Asset Management's IBB Position: Q3 2018 in Review

Shamrock Asset Management sold out of iShares Biotechnology ETF (IBB) in Q3 2018, closing a stake of 3,749 shares — an estimated $412K sold.

Shamrock Asset Management first reported a position in IBB in Q2 2013 and held it in 17 quarters. The position peaked at $2.48M in Q4 2014. 630 funds tracked by Wall St. Rank hold IBB as of Q3 2018.

Shamrock Asset Management reported no remaining iShares Biotechnology ETF position as of Q3 2018 after selling out during the quarter.
Shamrock Asset Management sold 3,749 iShares Biotechnology ETF shares in Q3 2018, an estimated $412K.
Shamrock Asset Management first reported a position in iShares Biotechnology ETF in Q2 2013 and held it in 17 quarters.
Shamrock Asset Management's iShares Biotechnology ETF position peaked at $2.48M in Q4 2014.
630 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2018.

Based on Shamrock Asset Management's 13F filing for Q3 2018, filed 23 Oct 2018.